Hepatic insulin clearance is reduced in patients with liver failure, leading to an increase in glycosylation end products, hypoxia and hypoxia-induced factors, that reduce liver blood supply and inhibit liver regeneration [20], thus affecting the prognosis of patients. This evidence concerns the gene INS and liver failure.